Mideast Stocks - Factors to watch on October 11
Qatar index leads major Gulf markets higher
Reuters News - 11 Oct 2020
Dallah Healthcare Company (4004.SE)
Also known as: DHC, Dallah Health
53.90 SAR -0.50-0.92%
DHC Stock Price & Performance
Recommendation
-
Div Yield
-
P/E (Last 12 Month)
31.22
Upside
-
Target Price (Mean)
-
Open
54.80 SAR
Previous Close
53.90 SAR
Turnover
14.57M SAR
EPS
1.752 SAR
Volume
267,237
Transactions
620
Market Cap
4.61B SAR
IPO Date
16-Dec-2012
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Dallah Healthcare Company
Business Summary
Ownership and operation of general hospitals. Through its main subsidiaries, manufacture of branded drugs; distribution of pharmaceuticals; offers hospital and medical center maintenance services.
Country of Incorporation
Ownership Type
Established In
1994
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| 4004.SSE | Ordinary | SAR | Saudi SE | 4004 |
Contact details
Primary address
Building: Al Nakheel TowerStreet: King Fahad Road 1157
Floor: 2nd Floor
Area: Al Nakheel Area
P.O. Box: 87833
Country: Saudi Arabia
City: Riyadh
City Suffix: 12381
CONTACT
- Tel: +966 11-299-5555
- Tel: +966 11-225-5065
- Tel: +966 11-225-5769
- Fax: +966 11-470-2748
- Fax: +966 11-225-0602
- Fax: +966 11-455-0803
- Email: info@dallahhealth.com
- www.dallahhealth.com
Region
RiyadhOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Ahmad Bin Saleh Mohammed Babaeer
Chief Executive Officer and Managing Director
Mr Khalid Mohammed Ali Al Saudi
Chief Financial Officer
Dr Salah Rashed Al Faqih
Chief of Medical Staff
Board Members
Mr Tariq Al Qusabi
Chairman
Mr Mohieddine Saleh Abdullah Kamel
Vice Chairman
Dr Mohammed Rashed Mohammed Al Fagih
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Zawya Coverage
UAE's Flydubai sees strong demand for Romania-UAE route
Saudi Cable plans to raise $96mln via rights issue
S&P downgrades Qatari Ezdan Holding on higher default risk
Saudi's MEPCO signs $32.8mln deal as part of tissue factory project
$163,000 fine slapped on individual for anti-money laundering law violations in UAE
Thursday Outlook: Asian shares jump as Fed chair eases concerns; oil prices rise
Dollar hits fresh three-year lows against commodity-linked currencies
Stock Market Data
Powered By Knowledge Direct